Article
Congenital Neutropenia With Specific Granulocyte Deficiency Caused By Novel Double Heterozygous SMARCD2 Mutations: is there a benefit of thrombopoietin receptor agonist therapy?
2024-01-31
Abstract excerpt
SMARCD2 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily D, member 2) is critical for myelopoiesis. Recently, bi-allelic SMARCD2 mutations have been reported in five children causing autosomal recessive congenital neutropenia with specific granulocytes deficiency (CN-SGD); a syndrome resulting in G-CSF resistant neutropenia, recurrent infections and dysplastic myelopoiesis. We...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 840fa5d4-6036-596d-ad3b-658ee46f8c44
- DOI
- 10.22541/au.170669090.00774557/v1
